4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: Potent and selective p70S6 kinase inhibitors
Тип публикации: Journal Article
Дата публикации: 2009-09-01
SCImago Q2
WOS Q2
БС2
SJR: 0.426
CiteScore: 4.5
Impact factor: 2.3
ISSN: 0960894X, 14643405
PubMed ID:
19632115
Organic Chemistry
Drug Discovery
Biochemistry
Molecular Biology
Pharmaceutical Science
Clinical Biochemistry
Molecular Medicine
Краткое описание
We report herein the design and synthesis of 4-(benzimidazol-2-yl)-1,2,5-oxadiazol-3-amine derivatives as inhibitors of p70S6 kinase. Screening hits containing the 4-(benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine scaffold were optimized for p70S6K potency and selectivity against related kinases. Structure-based design employing an active site homology model derived from PKA led to the preparation of benzimidazole 5-substituted compounds 26 and 27 as highly potent inhibitors ( K i <1 nM) of p70S6K, with >100-fold selectivity against PKA, ROCK and GSK3.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.
Топ-30
Журналы
|
1
|
|
|
Current Medicinal Chemistry
1 публикация, 4.55%
|
|
|
Oncotarget
1 публикация, 4.55%
|
|
|
Frontiers in Cell and Developmental Biology
1 публикация, 4.55%
|
|
|
Molecular Diversity
1 публикация, 4.55%
|
|
|
Journal of Structural and Functional Genomics
1 публикация, 4.55%
|
|
|
Neuropharmacology
1 публикация, 4.55%
|
|
|
Russian Chemical Reviews
1 публикация, 4.55%
|
|
|
European Journal of Medicinal Chemistry
1 публикация, 4.55%
|
|
|
European Journal of Pharmacology
1 публикация, 4.55%
|
|
|
Bioorganic and Medicinal Chemistry Letters
1 публикация, 4.55%
|
|
|
Tetrahedron
1 публикация, 4.55%
|
|
|
Journal of Organic Chemistry
1 публикация, 4.55%
|
|
|
Journal of Medicinal Chemistry
1 публикация, 4.55%
|
|
|
Journal of Biomolecular Structure and Dynamics
1 публикация, 4.55%
|
|
|
Journal of Clinical Pathology
1 публикация, 4.55%
|
|
|
International Journal of Alzheimer's Disease
1 публикация, 4.55%
|
|
|
ACS Omega
1 публикация, 4.55%
|
|
|
MolBank
1 публикация, 4.55%
|
|
|
New Journal of Chemistry
1 публикация, 4.55%
|
|
|
Chemical Biology and Drug Design
1 публикация, 4.55%
|
|
|
Crystal Growth and Design
1 публикация, 4.55%
|
|
|
RSC Medicinal Chemistry
1 публикация, 4.55%
|
|
|
1
|
Издатели
|
1
2
3
4
5
|
|
|
Elsevier
5 публикаций, 22.73%
|
|
|
American Chemical Society (ACS)
4 публикации, 18.18%
|
|
|
Springer Nature
2 публикации, 9.09%
|
|
|
Royal Society of Chemistry (RSC)
2 публикации, 9.09%
|
|
|
Bentham Science Publishers Ltd.
1 публикация, 4.55%
|
|
|
Impact Journals
1 публикация, 4.55%
|
|
|
Frontiers Media S.A.
1 публикация, 4.55%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 4.55%
|
|
|
Taylor & Francis
1 публикация, 4.55%
|
|
|
BMJ
1 публикация, 4.55%
|
|
|
Hindawi Limited
1 публикация, 4.55%
|
|
|
MDPI
1 публикация, 4.55%
|
|
|
Wiley
1 публикация, 4.55%
|
|
|
1
2
3
4
5
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Войти с ORCID
Метрики
22
Всего цитирований:
22
Цитирований c 2025:
1
(4.55%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Bandarage U. K. et al. 4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: Potent and selective p70S6 kinase inhibitors // Bioorganic and Medicinal Chemistry Letters. 2009. Vol. 19. No. 17. pp. 5191-5194.
ГОСТ со всеми авторами (до 50)
Скопировать
Bandarage U. K., Hare B., Parsons J., Pham L., Marhefka C., Bemis G., Tang Q., Moody C. S., Rodems S., Shah S., Adams C. S., Bravo J., Charonnet E., Savic V., Come J. H., Green J. B. 4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: Potent and selective p70S6 kinase inhibitors // Bioorganic and Medicinal Chemistry Letters. 2009. Vol. 19. No. 17. pp. 5191-5194.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1016/j.bmcl.2009.07.022
UR - https://doi.org/10.1016/j.bmcl.2009.07.022
TI - 4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: Potent and selective p70S6 kinase inhibitors
T2 - Bioorganic and Medicinal Chemistry Letters
AU - Bandarage, Upul K
AU - Hare, Brian
AU - Parsons, Jonathan
AU - Pham, Ly
AU - Marhefka, Craig
AU - Bemis, Guy
AU - Tang, Qing
AU - Moody, Cameron Stuver
AU - Rodems, Steve
AU - Shah, Sundeep
AU - Adams, Christopher S
AU - Bravo, Jose
AU - Charonnet, Emmanuelle
AU - Savic, Vladimir
AU - Come, Jon H
AU - Green, Jeremy B.
PY - 2009
DA - 2009/09/01
PB - Elsevier
SP - 5191-5194
IS - 17
VL - 19
PMID - 19632115
SN - 0960-894X
SN - 1464-3405
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2009_Bandarage,
author = {Upul K Bandarage and Brian Hare and Jonathan Parsons and Ly Pham and Craig Marhefka and Guy Bemis and Qing Tang and Cameron Stuver Moody and Steve Rodems and Sundeep Shah and Christopher S Adams and Jose Bravo and Emmanuelle Charonnet and Vladimir Savic and Jon H Come and Jeremy B. Green},
title = {4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: Potent and selective p70S6 kinase inhibitors},
journal = {Bioorganic and Medicinal Chemistry Letters},
year = {2009},
volume = {19},
publisher = {Elsevier},
month = {sep},
url = {https://doi.org/10.1016/j.bmcl.2009.07.022},
number = {17},
pages = {5191--5194},
doi = {10.1016/j.bmcl.2009.07.022}
}
Цитировать
MLA
Скопировать
Bandarage, Upul K., et al. “4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: Potent and selective p70S6 kinase inhibitors.” Bioorganic and Medicinal Chemistry Letters, vol. 19, no. 17, Sep. 2009, pp. 5191-5194. https://doi.org/10.1016/j.bmcl.2009.07.022.
Ошибка в публикации?